Submission of Audited Financial Results under Regulation 33 of SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015, for the Quarter and Year Ended 31 March 2025.
BI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bilcare Limited submitted its audited standalone and consolidated financial results for Q4 and FY ended 31 March 2025. On a standalone basis, revenue from operations declined to Rs. 15.12 crores (from Rs. 17.60 crores in FY24), but the company swung to a net profit of Rs. 3.99 crores for FY25 compared to Rs. 5.34 crores in FY24. Q4 FY25 standalone net profit stood at Rs. 3.36 crores versus a loss of Rs. 2.49 crores in Q4 FY24. On a consolidated basis, revenue grew to Rs. 788.04 crores (from Rs. 747.18 crores), but the company reported a net loss of Rs. 56.16 crores (slightly improved from Rs. 58.53 crores loss). The Board did not recommend any dividend. The auditor flagged a material uncertainty on going concern due to consecutive past losses and highlighted emphasis of matter items including a Rs. 12.57 crore CSIR loan penalty treated as contingent liability, ongoing SFIO investigation, and public fixed deposit liabilities.
Shareholders should note the auditor's material uncertainty on going concern, the ongoing SFIO investigation, and the continued consolidated losses despite revenue growth. Q4 improvement was largely driven by exceptional items like a Rs. 15.31 crore gain from sale of Thane factory land, which is not from core operations.